Patient-Focused Digital Measure Reports
This library is inspired by the FDA's Patient-Focused Drug Development (PFDD) initiative's goal of better incorporating the patient's voice in drug development and evaluation, and leverages information from their comprehensive collection of Voice of the Patient Reports.
Patient-Focused Digital Measure Reports
This library is inspired by the FDA's Patient-Focused Drug Development (PFDD) initiative's goal of better incorporating the patient's voice in drug development and evaluation, and leverages information from their comprehensive collection of Voice of the Patient Reports.
For each indication listed, we aim to relate the most significant symptoms described by patients to meaningful aspects of health that can be assessed using digital measures, highlighting opportunities for researchers to use data from medical-grade wearable DHTs to support patient-centric drug development. This information is summarized in the table below, and more details are provided in the indication-specific reports.
Read more about the inspiration for the library in this blog.
Therapeutic Area | Indication | Most Significant Symptoms Reported by Patients | Meaningful Aspects of Health | Candidate Digital Measures | Digital Measures Report |
---|---|---|---|---|---|
Neurology | Parkinson's Disease |
|
|
|
View Report |
Cardiology | Hypertrophic Cardiomyopathy (HCM) |
|
|
|
View Report |
Dermatology | Atopic Dermatitis (Eczema) |
|
|
|
View Report |
Respirology | Idiopathic Pulmonary Fibrosis (IPF) |
|
|
|
View Report |
Respirology | Obstructive Sleep Apnea (OSA) |
|
|
|
View Report |
Cardiology | Pulmonary Arterial Hypertension (PAH) |
|
|
|
View Report |
Dermatology | Psoriasis |
|
|
|
View Report |
Neurology | Narcolepsy |
|
|
|
View Report |
Respirology | Asthma |
|
|
|
View Report |
Rheumatology | Osteoarthritis (OA) |
|
|
|
View Report |
Oncology | Cancer Cachexia |
|
|
|
View Report |
Neurology | Myotonic Dystrophy (DM) |
|
|
|
View Report |
Neurology | Spinal Muscular Atrophy (SMA) |
|
|
|
View Report |
Neurology | Kennedy’s Disease (KD) / Spinal and bulbar muscular atrophy (SBMA) |
|
|
|
View Report |
Neurology | Amyotrophic Lateral Sclerosis (ALS) |
|
|
|
View Report |
Neurology | Huntington's Disease |
|
|
|
View Report |
Metabolic and Endocrinology | Nonalcoholic Steatohepatitis (NASH) |
|
|
|
Coming Soon |
Neurology | Sarcopenia |
|
|
|
Coming Soon |
Rheumatology | Systemic Sclerosis |
|
|
|
Coming Soon |
Rheumatology | Inclusion Body Myositis (IBM) |
|
|
|
Coming Soon |
For each indication listed, we aim to relate the most significant symptoms described by patients to meaningful aspects of health that can be assessed using digital measures, highlighting opportunities for researchers to use data from medical-grade wearable DHTs to support patient-centric drug development. This information is summarized in the table above, and more details are provided in the digital measures report.
Read more about the inspiration for the library in this blog.
Digital Endpoint Guides
Access our Digital Endpoint Guides for more information about how the use of digital endpoints can advance clinical research in specific therapeutic areas.
Voice of the Patient
Based on Voice of the Patient meeting reports from the FDA PFDD initiative, we summarize the most significant symptoms reported by patients.
Related Measures
We outline the related measures that sensor-based wearable DHTs could help clinical researchers capture and relate them to indication-specific symptoms.
Digital Endpoint Guides
Links to therapeutic area specific Digital Endpoint Guides can provide further information about developing digital endpoints for clinical research.
Schedule a Meeting with a Member of our Team
Schedule a meeting with a member of our team to discuss which patient-focused digital measures are right for your trial.